AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For Magellan Aerospace, the core investment case rests on believing in its ability to convert a pipeline of defence and commercial aerospace programs into steadily improving earnings, while justifying a relatively rich earnings multiple. Recent results show higher sales and profitability, supported by long-term customer relationships, regular dividends and a modest buyback, which together hint at a management team focused on shareholder returns. The new M‑72 Light Anti‑Tank Weapon contract fits into this story as a potentially meaningful, though not transformational, short term catalyst: it embeds Magellan more deeply in Canada’s defence industrial framework and could broaden its defence revenue base alongside existing engine, submarine and space contracts. At the same time, the share price has already moved sharply higher, so valuation, execution risk on new programs and relatively low return on equity remain front of mind.
However, investors should be aware of how quickly expectations and valuation have already moved. Magellan Aerospace's shares have been on the rise but are still potentially undervalued by 13%. Find out what it's worth.Explore 2 other fair value estimates on Magellan Aerospace - why the stock might be worth just CA$40.07!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com